March 27th 2019
By Kristie L. Kahl
Barriers to treatment can be an uphill battle for patients with cancer; however, one company is here to help.
March 20th 2019
By Brielle Benyon
During the 2019 Miami Breast Cancer Conference, an expert discussed financial toxicity and the role of healthcare providers in addressing the cost of care with their patients.
March 9th 2019
By Bernadette O'Donoghue
Medical care for blood cancer imposes high out-of-pocket costs for patients and families.
February 26th 2019
By A. Mark Fendrick & Dan Klein
Of all the health care regulations coming out of the current administration, the recent drug rebate proposal presents a new opportunity to significantly lower out-of-pocket prescription drug costs for Medicare patients. But like most things in health care, there is more complexity to the administration’s proposed changes to pharmaceutical company rebates than initially meets the eye.
February 21st 2019
By Len Lichtenfeld, M.D.
Shouldn’t we at least have the courtesy to supply the drug at no cost to those who took it as part of the trial?
February 6th 2019
President Donald J. Trump announced his plan to amp up the fight against childhood cancer, and to lower prescription drug costs.
January 23rd 2019
By Tamera Anderson-Hanna
Many federal employees and their dependents may be anxious about paying their medical bills.
January 17th 2019
A recent survey demonstrated the common tradeoffs most patients report regarding treatment decisions, highlighting the importance of shared decision making.
December 11th 2018
By Bonnie Annis
The high cost of treatment for cancer places a heavy burden on patients and their families, often leading to stress-related illnesses. Is there a solution?
November 28th 2018
By Shira Zwebner
Even living in a country with socialized medicine, cancer debt is an unfortunate side effect of treatment, making holiday shopping a challenge
How Can Self-Advocacy Improve Care for Newly Diagnosed Patients?
Venclexta Treatment Combo is Being Reviewed by FDA For CLL
July Lung Cancer Highlights: Top 5 Updates Patients Should Know
Jaypirca Shows Improvements Over Imbruvica in CLL/SLL